2d
Clinical Trials Arena on MSNBioCity and MSD to evaluate cancer treatment combination in Phase I/II trialBioCity Biopharmaceuticals and MSD have signed a clinical trial partnership agreement to assess BC3195 in conjunction with ...
3d
Clinical Trials Arena on MSNVir enrols first subject in Phase III programme to assess CHD therapyThe programme includes the ECLIPSE 1 and ECLIPSE 2 Phase III trials, aiming to offer registrational data for regulatory submissions.
Updated Phase 1 data for ELVN-001 expected mid-2025 as positive enrollment momentum continues Expected monotherapy and combination data from the ELVN-002 Phase 1 trials ...
YourChoice Therapeutics, Inc., pioneering hormone-free family planning products, announced today that Communications Medicine, a Nature Portfolio journal, has published a peer-reviewed paper on the ...
Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today reported financial results for the ...
TRIFOUR is Cantargia's first randomized, controlled study of nadunolimabFirst preliminary efficacy results expected mid-2025 LUND, SWEDEN / ACCESS Newswire / March 10, 2025 / Cantargia (Cantargia AB); ...
R-708-5p is a stress-regulated microRNA and a potential biomarker for the differential diagnosis of human mood disorders.
SFA Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel oral small-molecule biosynthetic ...
Avacta Therapeutics (AIM: AVCT), a life sciences company developing next generation peptide drug conjugates (PDC) targeting powerful anti-tumor payloads directly to ...
Amgen and CytomX Therapeutics have kicked a phase 1 T-cell engager to the curb, axing the asset after assessing the clinical ...
Nuvectis Pharma, Inc.’s NVCT share price has surged by 12.68%, which has investors questioning if this is right time to sell.
Assembly Biosciences, Inc. (NASDAQ:ASMB – Get Free Report) was the target of a significant growth in short interest in February. As of February 15th, there was short interest totalling 17,200 shares, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results